Mylan N.V. (NASDAQ: MYL) announced the U.S. Federal Trade Commission ("FTC") has cleared the company's proposed transaction to acquire Perrigo Company plc (NYSE: PRGO; TASE) subject to Mylan's divestiture of certain products following the consummation of the offer. The FTC clearance represents the final regulatory clearance needed by Mylan to close its acquisition of Perrigo and represents the last remaining condition that needs to be satisfied for the successful completion of the offer other than the acceptance condition.
Mylan's Executive Chairman Robert J. Coury said, "We are delighted to have received FTC clearance, making our offer for Perrigo now unconditional other than the one final step, which now rests solely in the hands of Perrigo shareholders. We are very confident that Perrigo shareholders will support this transaction by tendering their shares by 8:00 am ET on Nov. 13, 2015."
In this regard, following the successful completion of acquisition of Perrigo, and previously announced steps to cancel the Mylan preferred shares issued to the stichting, Mylan said it will submit changes to corporate governance for a vote by shareholders of the combined Mylan-Perrigo entity at its next annual general meeting, including proposals regarding whether or not to retain the stichting structure as well as the process for nomination and election of directors.
As per the terms of Mylan's offer, Perrigo shareholders will receive $75 in cash and 2.3 Mylan ordinary shares for each Perrigo ordinary share. On September 14, 2015 Mylan officially commenced its formal offer to acquire all outstanding ordinary shares of Perrigo.
Subscribe to PharmaTutor News Alerts by Email >>
